# Clinical Study of Neoantigen Vaccine Combined With Targeted Drugs in the Treatment of Non-small Cell Lung Cancer

> **NCT04487093** · PHASE1 · UNKNOWN · sponsor: **First Hospital of Shijiazhuang City** · enrollment: 20 (estimated)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **DRUG:** neoantigen vaccine + EGFR-TKI
- **DRUG:** neoantigen vaccine + anti-angioge

## Key facts

- **NCT ID:** NCT04487093
- **Lead sponsor:** First Hospital of Shijiazhuang City
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-17
- **Primary completion:** 2022-05-17
- **Final completion:** 2022-12-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2020-07-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04487093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04487093, "Clinical Study of Neoantigen Vaccine Combined With Targeted Drugs in the Treatment of Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04487093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*